Department of Infectious Diseases, Leiden University Medical Center, 2300 RC Leiden, the Netherlands.
J Infect. 2010 Feb;60(2):114-21. doi: 10.1016/j.jinf.2009.11.008. Epub 2009 Nov 27.
Home-based treatment of acute pyelonephritis (AP) is generally reserved for young non-pregnant women who lack co-morbidity. This study, focusing on the elderly and patients with co-morbidity, evaluates the Dutch primary care guideline that recommends referral to hospital only in case of suspected deterioration to severe sepsis or failure of antibiotic treatment, irrespective of patient's age, sex or co-morbidity.
A prospective observational cohort study including consecutive non-pregnant adults with AP. Clinical and microbiological outcome measures of non-referred patients from 35 primary health care centres (PHC) were compared to patients referred to two affiliating emergency departments (EDs).
Of 395 evaluable patients, 153 were treated by PHCs and 242 referred to EDs. The median age was 63years [IQR 43-77], 34% were male, 58% had co-morbidity; all comparable between the PHC and ED group. Referred ED patients were more likely to have signs of sepsis and to have been pre-treated with antibiotics. Bacteraemia was present in 10% of patients in the PHC group and 27% in the ED group (RR 2.83; 95% CI: 1.64-4.86, p<0.001). Eight (5%) PHC patients were admitted during outpatient treatment but otherwise no major complications occurred. Clinical failure rates at 30days were similar between PHC patients and ED patients; 9% and 10% respectively. Mortality rates of PHC patients versus ED patients were 1% versus 5% at 30days (p=0.058) and 1% versus 7% at 90days (p=0.007). Complicated outcome occurred in 6% of the PHC patients versus 12% in the patients referred to ED (p=0.067).
In a health care system with a well-organized primary care system and clear guideline, the outcome of adults with acute pyelonephritis, including men, the elderly and patients with co-morbidity, selected for oral antibiotic treatment at home did not lead to major complications.
急性肾盂肾炎(AP)的家庭治疗通常仅适用于年轻、无合并症的非孕妇。本研究聚焦于老年患者和合并症患者,评估荷兰初级保健指南,该指南建议仅在疑似恶化为严重脓毒症或抗生素治疗失败的情况下将患者转诊至医院,而不论患者年龄、性别或合并症如何。
一项包括连续非孕妇的急性肾盂肾炎的前瞻性观察队列研究。比较了来自 35 个初级保健中心(PHC)的未转诊患者的临床和微生物学结局指标与转诊至两家附属急诊部门(ED)的患者。
在 395 例可评估的患者中,153 例在 PHC 治疗,242 例转诊至 ED。中位年龄为 63 岁[IQR 43-77],34%为男性,58%有合并症;PHC 和 ED 组之间无差异。转诊至 ED 的患者更有可能出现脓毒症迹象,并已接受抗生素预治疗。PHC 组中 10%的患者存在菌血症,而 ED 组中 27%的患者存在菌血症(RR 2.83;95%CI:1.64-4.86,p<0.001)。8 例(5%)PHC 患者在门诊治疗期间住院,但无其他重大并发症发生。30 天时 PHC 患者和 ED 患者的临床失败率相似;分别为 9%和 10%。30 天时 PHC 患者与 ED 患者的死亡率分别为 1%和 5%(p=0.058),90 天时分别为 1%和 7%(p=0.007)。PHC 患者的复杂结局发生率为 6%,而转诊至 ED 的患者为 12%(p=0.067)。
在一个初级保健系统组织良好且指南明确的医疗保健系统中,选择在家中口服抗生素治疗的急性肾盂肾炎成人,包括男性、老年人和合并症患者,其结局并未导致重大并发症。